Skip to main content

COVID-19

      RT @Janetbirdope: Please don’t miss MISC (pronounced Miss C)=multisystem inflammatory syndrome. Pediatric syndrome pos
      3 years 1 month ago
      Please don’t miss MISC (pronounced Miss C)=multisystem inflammatory syndrome. Pediatric syndrome post #SARSCoV2 infection. May go w macrophage activation syndrome (MAS) w distinct proteomics signature. Potentially v poor outcomes. Need to dx and treat #ACR21 abst0961 @RheumNow https://t.co/uaBbUdg3lt
      RT @_Castillo_Pedro: Dr. Petri on COVID19 infection vs vaccination on SLE activity:
      💠Infection = NO increase SLE acti
      3 years 1 month ago
      Dr. Petri on COVID19 infection vs vaccination on SLE activity: 💠Infection = NO increase SLE activity 💠Infection =⬇️ cutaneous activity 💠Infection = ⬆️anti-cardiolipin IgG/M 💠Vaccination: no increase in activity NOR aCL IgG/M https://t.co/fWbotSLS3o #ACR21 Abst#0858 @RheumNow
      RT @AkhilSoodMD: Abstr 0983 mRNA SARS-CoV-2 Vaccine in RA Patients

      Rubbert-Roth and colleagues found:
      - RA patients dev
      3 years 1 month ago
      Abstr 0983 mRNA SARS-CoV-2 Vaccine in RA Patients Rubbert-Roth and colleagues found: - RA patients developed anti-S1 antibodies slower and lower compared to controls - Reduced titers among Abatacept & JAKi users #ACR21 @RheumNow https://t.co/sXW8d53O8m
      RT @Yuz6Yusof: #ACR21 #Abstr0866 Data from #COVID19 GRA Registry showed predictors of poor COVID outcome in 1922 #lupus
      3 years 1 month ago
      #ACR21 #Abstr0866 Data from #COVID19 GRA Registry showed predictors of poor COVID outcome in 1922 #lupus pts: Older age Male Areas outside Europe, 🇺🇸🇨🇦 Infection <June 2020 Any Corticosteroid dose Not on therapy On Rituximab Comorbidities ⬆️disease activity @RheumNow #ACRBest https://t.co/u0GF3aDsFA
      RT @Yuz6Yusof: #ACR21 #Abstr0858 Petri reported effect of #COVID and vaccination in #lupus cohort
      💠No increase in act
      3 years 1 month ago
      #ACR21 #Abstr0858 Petri reported effect of #COVID and vaccination in #lupus cohort 💠No increase in activity post-infection 💠⬇️cutaneous activity 💠⬆️ aCL IgG and IgM post-infection, 💠No increase in SLE activity or aCL abs post-vaccination @RheumNow https://t.co/iAaIfzf33c https://t.co/hA6sk6icrs
      RT @DrPetryna: Andy 0963 #ACR21 @RheumNow covid19 vaccine immunogenicity in rheum pts overall good at 71%, fairly depend
      3 years 1 month ago
      Andy 0963 #ACR21 @RheumNow covid19 vaccine immunogenicity in rheum pts overall good at 71%, fairly dependent on Rx choice: rituximab 38% after 1g & only 7 % after 1gx2; abatacept IV 45%. Rest biologics >80%, ⬇️MTX &MMF. Low dose prednisone w/out biologics did not affect Ab+ rates https://t.co/TkCC1sgMHG
      RT @rheum_cat: Infx oral session

      0964 Bitoun, et al.

      RTX lowers neutralizing Ab response compared to healthy controls,
      3 years 1 month ago
      Infx oral session 0964 Bitoun, et al. RTX lowers neutralizing Ab response compared to healthy controls, after COVID vaccination -- more supportive data https://t.co/6jvWHSjIgr #ACR21
      Outcomes of COVID-19 in Patients with Rheumatoid Arthritis.

      Dr. Akhil Sood ( @AkhilSoodMD) shares the studies presente
      3 years 1 month ago
      Outcomes of COVID-19 in Patients with Rheumatoid Arthritis. Dr. Akhil Sood ( @AkhilSoodMD) shares the studies presented #ACR21. https://t.co/yrs8N8XSiS https://t.co/EKHuTS5aDr
      ×